JLK Inc (322510) - Cash Flow Conversion Efficiency
Based on the latest financial reports, JLK Inc (322510) has a cash flow conversion efficiency ratio of -0.052x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-2.42 Billion ≈ $-1.64 Million USD) by net assets (₩46.99 Billion ≈ $31.84 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JLK Inc (322510) liquidity interval to measure how many days the company can operate on defensive assets alone.
JLK Inc - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how JLK Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
JLK Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of JLK Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ensari Deri Gida Sanayi ve Ticaret AS
IS:ENSRI
|
0.094x |
|
Verrica Pharmaceuticals Inc
NASDAQ:VRCA
|
-0.571x |
|
Fidelix Co. Ltd
KQ:032580
|
-0.050x |
|
Korea Cast Pip
KO:000970
|
0.004x |
|
Sambo Corrugated Board Co. Ltd
KQ:023600
|
0.016x |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
0.004x |
|
Panasonic Manufacture Malaysia
KLSE:3719
|
0.002x |
|
Dekuple
PA:DKUPL
|
0.153x |
Annual Cash Flow Conversion Efficiency for JLK Inc (2017–2024)
The table below shows the annual cash flow conversion efficiency of JLK Inc from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see market value of JLK Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩49.32 Billion ≈ $33.42 Million |
₩-10.94 Billion ≈ $-7.41 Million |
-0.222x | +59.24% |
| 2023-12-31 | ₩11.72 Billion ≈ $7.95 Million |
₩-6.38 Billion ≈ $-4.32 Million |
-0.544x | -14.45% |
| 2022-12-31 | ₩16.62 Billion ≈ $11.26 Million |
₩-7.90 Billion ≈ $-5.35 Million |
-0.475x | -87.81% |
| 2021-12-31 | ₩24.08 Billion ≈ $16.32 Million |
₩-6.10 Billion ≈ $-4.13 Million |
-0.253x | -88.59% |
| 2020-12-31 | ₩30.67 Billion ≈ $20.78 Million |
₩-4.12 Billion ≈ $-2.79 Million |
-0.134x | +24.14% |
| 2019-12-31 | ₩36.30 Billion ≈ $24.60 Million |
₩-6.42 Billion ≈ $-4.35 Million |
-0.177x | +71.77% |
| 2018-12-31 | ₩6.10 Billion ≈ $4.13 Million |
₩-3.82 Billion ≈ $-2.59 Million |
-0.627x | -268.97% |
| 2017-12-31 | ₩-8.64 Billion ≈ $-5.86 Million |
₩-3.21 Billion ≈ $-2.17 Million |
0.371x | -- |
About JLK Inc
JLK, Inc. provides diagnosis support to the patients with its AI-driven medical platform in South Korea. The company offers AI medical and AI security solutions. Its AI platform provides on-site/real-time service that is connected to various systems built in the hospital and enables the professional needs of physicians to diagnose diseases. The company provides medical management, medical treatme… Read more